Reimbursement pricing for new medical devices in Japan: Is the evaluation of innovation appropriate?

OBJECTIVES: In Japan, strong reimbursement pricing control measures for existing medical device products have rendered new medical device reimbursement pricing critical for manufacturers. Few studies have been conducted on this aspect; therefore, this paper (1) clarifies whether evaluation of innova...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, Makoto, Nakano, Shohei, Sugahara, Takuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686657/
https://www.ncbi.nlm.nih.gov/pubmed/30549085
http://dx.doi.org/10.1002/hpm.2719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686657/
https://www.ncbi.nlm.nih.gov/pubmed/30549085
http://dx.doi.org/10.1002/hpm.2719

Ejemplares similares